Cover Image

A retrospective analysis of severe asthma treatment with Mepolizumab

<p>Among the different types of bronchial asthma, the allergic one is certainly the most easily found. Allergic asthma is characterized by the presence of IgE antibodies called "reagine", responsible for triggering respiratory allergic crises in the presence of perennial or seasonal...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mattia Serao (Author), Rossana Vigliarolo (Author), Tiziana Trequattrini (Author), Angela Succu (Author), Marianna Lilli (Author), Rosario Rivitti (Author), Aldo Ciani (Author), Giulia Cacciani (Author), Sara Mannucci (Author), Maria Cristina Zappa (Author)
Format:	Book
Published:	Archives of Pulmonology and Respiratory Care - Peertechz Publications, 2019-09-24.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Severe Pediatric Asthma Therapy: Mepolizumab
by: Nicola Ullmann, et al.
Published: (2022)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
by: Menzella F, et al.
Published: (2016)

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
by: Mattia Giovannini, et al.
Published: (2019)

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
by: Manuel David Gil-Sierra, et al.
Published: (2019)

Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice
by: Olalla Montero-Pérez, et al.
Published: (2019)

Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma
by: A. G. Tolkushin, et al.
Published: (2019)

Use of Mepolizumab in Children and Adolescents with Asthma in the USA
by: Jaclyn Davis, et al.
Published: (2022)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
by: Pelaia C, et al.
Published: (2017)

Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab
by: Erminia Ridolo, et al.
Published: (2020)

Very long-term data on patients with severe eosinophilic asthma treated with mepolizumab: a case series
by: Carlo Lombardi, et al.
Published: (2024)

Mepolizumab in Severe Pediatric Asthma: Certainties and Doubts through a Single-Center Experience and Review of the Literature
by: Marco Maglione, et al.
Published: (2024)

Efficacy of Mepolizumab in the Treatment of Severe Asthma with a Mixed Granulocytic Pattern of Airway Inflammation (Case Report)
by: A. M. Gubareva, et al.
Published: (2024)

Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience
by: Anna Agnese Stanziola, et al.
Published: (2024)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
by: Menzella F, et al.
Published: (2017)

Budget Impact Analysis of Mepolizumab for Eligible Patients in the Setting of a Severe Asthma Clinic Within Dubai Health Authority (DHA)
by: Mahboub B, et al.
Published: (2022)

Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma
by: Christian Domingo, et al.
Published: (2023)

Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission
by: B. Cremonezi Lammoglia, et al.
Published: (2023)

Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review
by: Sara Munari, et al.
Published: (2024)

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study
by: Giovanna Elisiana Carpagnano, et al.
Published: (2020)

Mepolizumab-responsive recurrent eosinophilic eruption without peripheral eosinophilia
by: Nina B. Curkovic, MD, et al.
Published: (2024)

Mepolizumab: an alternative therapy for idiopathic chronic eosinophilic pneumonia with glucocorticoid intolerance
by: Adam Kisling, et al.
Published: (2020)

Valutazione dei disturbi del sonno in pazienti affetti da Long Covid: valutazione delle qualità psicometriche della versione italiana della General Sleep Disturbance Scale (GSDS).
by: Matteo Tamburlani, et al.
Published: (2024)

Earlier continuous administration of mepolizumab for eosinophilic granulomatosis with polyangiitis based on cutaneous findings
by: Takaharu Ikeda, et al.
Published: (2023)

Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone
by: Madeleine Lachance, MD, et al.
Published: (2022)

Pulmonary Rehabilitation and Asthma
by: Elisabetta Zampogna, et al.
Published: (2020)

Evaluation of physical activity before and after respiratory rehabilitation in normal weight individuals with asthma: a feasibility study
by: Federico Mattia Oliva, et al.
Published: (2024)

A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system
by: Huqun Li, et al.
Published: (2023)

Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options
by: Magdalena Żychowska, et al.
Published: (2020)

A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
by: Fan Zou, et al.
Published: (2023)

Frontiers Review: Severe Asthma in Adolescents
by: Sara Warraich, et al.
Published: (2022)

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
by: Faverio P, et al.
Published: (2018)

Case Report: Self-Administration of Omalizumab in an Adolescent With Severe Asthma During SARS-CoV-2 Infection
by: Erika Paladini, et al.
Published: (2021)

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
by: Wytske Fokkens, et al.
Published: (2023)

Overview on the treatment of severe bronchial asthma
by: Giulio Dinardo, et al.
Published: (2024)

Do not forget asthma comorbidities in pediatric severe asthma!
by: Lucia Ronco, et al.
Published: (2022)

From the Global Initiative for Asthma report and asthma guidelines to real-life asthma control: is there room for improvement?
by: Elio Novembre, et al.
Published: (2022)

Difficult and Severe Asthma in Children
Published: (2019)

Difficult and Severe Asthma in Children
by: Federica Porcaro, et al.
Published: (2020)

An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma
by: Gian Luigi Marseglia, et al.
Published: (2024)

A Brief Review of Severe Asthma
by: Muhammad Amin Ibrahim, et al.
Published: (2021)